Beta-L-(-)-dioxolane Cytidine (β-L-(-)-OddC) as a Potent Compound for the Treatment of Cancer

Abstract

L-(-)-OddC is the first nucleoside analog with the unnatural L-configuration and the first chain-terminator shown to have anti-cancer activity. This compound was found to be highly active against solid tumor growth in several human xenograft models. L-(-)-OddC exerts its activity be terminating DNA chain elongation after its incorporation.